Discover Great Companies Discover Great Clients

About the Company

Shanghai Xinya Pharmaceutical Co., Ltd. is a listed company under Shanghai Pharmaceuticals. Through strategic asset restructuring, Xinya Pharmaceutical acquired the intangible assets of Shanghai Xianfeng Pharmaceutical Co., Ltd., known as the "Cradle of China's Antibiotics," becoming one of the largest anti-infective pharmaceutical enterprises in China. Under Xinya Pharmaceutical, there are three well-known domestic brands: "Ya Zi" (亚字), "San Hua" (叁花), and "Si Xing" (四星). Its products cover almost all categories of anti-infective drugs, making it one of the domestic anti-infective manufacturers with the most complete range, richness, and distinctive features. The company's main products, including ceftriaxone, cefotaxime, cefoperazone, and cefotiam, rank among the top in the domestic market. Xinya Pharmaceutical values the development of human capital, advocates the talent management philosophy of "people as corporate capital," and strives to create a favorable working environment and ample career development opportunities for employees. It encourages employees to be proactive and innovative, continuously stimulating their work enthusiasm to achieve common development between the company and employees. The company implements a "dual-track" promotion system for management and technical positions, providing broad career growth paths for technical talents based on their career orientation and personality traits. The company emphasizes employee capability development through various training methods, including job rotation, project-based training, mentorship, expert apprenticeship, skills competitions, internal trainer systems, team building, and further education. Each year, the company ensures training investment of no less than 2% of total payroll, creating conditions for employees to enhance their knowledge and skills. The company values the use of young talent and has established various talent channels such as internal competitive recruitment. Young talents have become a major force in key management and technical positions within the enterprise. Welcome to join our team. We give you a sky to soar freely!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (1 open positions)

Manage
Note: How fast is hiring at Shanghai Xinya Pharmaceutical Co., Ltd. growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

honors, qualifications & industry associations

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 105,242.9132万(元)
Legal Representative: 唐坚豪
Date Established:
Credit Code: 91310115133738906M
Registered Address: 上海市浦东新区川沙路978号

Partners & Suppliers

向其销售原料药 Source
供应商 原料药销售

People who follow this company also follow

Competitors (Similar Companies)

“是国内低压电器行业高端市场的领先公司之一”
“A century-old national pharmaceutical enterprise”
医药 抗生素 制药/药业 肟
“A high-tech biotechnology enterprise dedicated to the research and dev”
医药 临床研究 小分子药物 仿制药
医药分销 医药供应链 试剂 疫苗
“One-stop CRO & CDMO services”
制药/药业 医药 化学制药 临床前研究
医药 制药/药业 研发 工艺优化
“An international biopharmaceutical company driven by innovative techno”
维生素 生物制品 医药中间体 氨基酸
“聚焦弥漫性胃癌等未被满足的临床治疗需求”
制药/药业 医药 医药工业
医药 试剂 药物研发 CRO

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates